<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8186192" created="27/10/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8186192</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Some <term id="T1" lex="antioxidants" sem="Organic_compound_other">antioxidants</term> inhibit, in a co-ordinate fashion, the production of <term id="T2" lex="tumor_necrosis_factor-alpha" sem="Protein_molecule">tumor necrosis factor-alpha</term>, <term id="T3" lex="IL-beta" sem="Protein_molecule">IL-beta</term>, and <term id="T4" lex="IL-6" sem="Protein_molecule">IL-6</term> by <term id="T5" lex="human_peripheral_blood_mononuclear_cell" sem="Cell_natural">human peripheral blood mononuclear cells</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="T2"/>
<clue>Some antioxidants inhibit, in a co-ordinate fashion, the <clueType>production</clueType> <linkTheme>of</linkTheme> tumor necrosis factor-alpha, IL-beta, and IL-6 <clueLoc>by human peripheral blood mononuclear cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="T3"/>
<clue>Some antioxidants inhibit, in a co-ordinate fashion, the <clueType>production</clueType> <linkTheme>of</linkTheme> tumor necrosis factor-alpha, IL-beta, and IL-6 <clueLoc>by human peripheral blood mononuclear cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="T4"/>
<clue>Some antioxidants inhibit, in a co-ordinate fashion, the <clueType>production</clueType> <linkTheme>of</linkTheme> tumor necrosis factor-alpha, IL-beta, and IL-6 <clueLoc>by human peripheral blood mononuclear cells</clueLoc>.</clue>
</event>
<event id="E4">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="T1"/>
<clue>Some antioxidants <clueType>inhibit</clueType>, in a co-ordinate fashion, the production of tumor necrosis factor-alpha, IL-beta, and IL-6 by human peripheral blood mononuclear cells.</clue>
</event>
<event id="E5">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="T1"/>
<clue>Some antioxidants <clueType>inhibit</clueType>, in a co-ordinate fashion, the production of tumor necrosis factor-alpha, IL-beta, and IL-6 by human peripheral blood mononuclear cells.</clue>
</event>
<event id="E6">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="T1"/>
<clue>Some antioxidants <clueType>inhibit</clueType>, in a co-ordinate fashion, the production of tumor necrosis factor-alpha, IL-beta, and IL-6 by human peripheral blood mononuclear cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Some <term id="T6" lex="antioxidants" sem="Organic_compound_other">antioxidants</term>, including <term id="T7" lex="butylated_hydroxyanisole" sem="Organic_compound_other">butylated hydroxyanisole</term> (<term id="T8" lex="BHA" sem="Organic_compound_other">BHA</term>), <term id="T9" lex="tetrahydropapaveroline" sem="Organic_compound_other">tetrahydropapaveroline</term> (<term id="T10" lex="THP" sem="Organic_compound_other">THP</term>), <term id="T11" lex="nordihydroguiauretic_acid" sem="Organic_compound_other">nordihydroguiauretic acid</term>, and <term id="T12" lex="10,11-dihydroxyaporphine" sem="Organic_compound_other">10,11-dihydroxyaporphine</term> (<term id="T13" lex="DHA" sem="Organic_compound_other">DHA</term>), were found to be potent inhibitors of the production of <term id="T14" lex="tumor_necrosis_factor_(TNF)-alpha" sem="Protein_molecule">tumor necrosis factor (TNF)-alpha</term>, <term id="T15" lex="IL-1_beta" sem="Protein_molecule">IL-1 beta</term>, and <term id="T16" lex="IL-6" sem="Protein_molecule">IL-6</term> by <term id="T17" lex="human_peripheral_blood_mononuclear_cell" sem="Cell_natural">human peripheral blood mononuclear cells</term> (<term id="T18" lex="PBMC" sem="Cell_natural">PBMC</term>) stimulated by <term id="T19" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> (<term id="T20" lex="LPS" sem="Lipid">LPS</term>) (<term id="T21" lex="IC50" sem="Other">IC50s</term> in the low micromolar range).</sentence>
<event KT="Other" id="E7">
<type class="Gene_expression"/>
<theme idref="T14"/>
<clue>Some antioxidants, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were found to be potent inhibitors of the <clueType>production</clueType> <linkTheme>of</linkTheme> tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 <clueLoc>by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range)</clueLoc>.</clue>
</event>
<event KT="Other" id="E8">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>Some antioxidants, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were found to be potent inhibitors of the <clueType>production</clueType> <linkTheme>of</linkTheme> tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 <clueLoc>by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range)</clueLoc>.</clue>
</event>
<event KT="Other" id="E9">
<type class="Gene_expression"/>
<theme idref="T16"/>
<clue>Some antioxidants, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were found to be potent inhibitors of the <clueType>production</clueType> <linkTheme>of</linkTheme> tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 <clueLoc>by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range)</clueLoc>.</clue>
</event>
<event Manner="High" id="E10">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="T6"/>
<clue>Some antioxidants, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E11">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T6"/>
<clue>Some antioxidants, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E12">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T6"/>
<clue>Some antioxidants, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E13">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="T8"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E14">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T8"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E15">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T8"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E16">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="T10"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E17">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T10"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E18">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T10"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E119">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="T11"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E120">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T11"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E121">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T11"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E19">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="T13"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E20">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T13"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event Manner="High" id="E21">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T13"/>
<clue><corefCause>Some antioxidants</corefCause>, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were <clueKT>found</clueKT> to be <clueManner>potent</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<event id="E22">
<type class="Physiological_process"/>
<theme idref="T18"/>
<cause idref="T20"/>
<clue>Some antioxidants, including butylated hydroxyanisole (BHA), tetrahydropapaveroline (THP), nordihydroguiauretic acid, and 10,11-dihydroxyaporphine (DHA), were found to be potent inhibitors of the production of tumor necrosis factor (TNF)-alpha, IL-1 beta, and IL-6 by human peripheral blood mononuclear cells (PBMC) <clueType>stimulated</clueType> <linkCause>by</linkCause> lipopolysaccharide (LPS) (IC50s in the low micromolar range).</clue>
</event>
<sentence id="S3">Inhibition of <term id="T22" lex="cytokine_production" sem="Other"><term id="T23" lex="cytokine" sem="Protein_family_or_group">cytokine</term> production</term> was gene selective and not due to general effects on <term id="T24" lex="protein_synthesis" sem="Other">protein synthesis</term>.</sentence>
<event KT="Other" id="E26">
<type class="Gene_expression"/>
<theme idref="T23"/>
<clue>Inhibition of cytokine <clueType>production</clueType> was gene selective and not due to general effects on protein synthesis.</clue>
</event>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production was gene selective and not due to general effects on protein synthesis.</clue>
</event>
<event KT="Other" id="E28">
<type class="Regulation"/>
<theme idref="T24"/>
<clue>Inhibition of cytokine production was gene selective and not due to <clueType>general effects</clueType> <linkTheme>on</linkTheme> protein synthesis.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E29">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="E28"/>
<clue>Inhibition of cytokine production was gene selective and <cluePolarity>not</cluePolarity> <clueType>due</clueType> <linkCause>to</linkCause> general effects on protein synthesis.</clue>
</event>
<sentence id="S4">Inhibition of <term id="T25" lex="cytokine_production" sem="Other"><term id="T26" lex="cytokine" sem="Protein_family_or_group">cytokine</term> production</term> by <term id="T27" lex="PBMC" sem="Cell_natural">PBMC</term> was observed also when other inducers were used (<term id="T28" lex="staphylococci" sem="Unicellular_organism">staphylococci</term>, <term id="T29" lex="silica" sem="Inorganic_compound">silica</term>, <term id="T30" lex="zymosan" sem="Carbohydrate">zymosan</term>).</sentence>
<event KT="Other" id="E30">
<type class="Gene_expression"/>
<theme idref="T26"/>
<clue>Inhibition of cytokine <clueType>production</clueType> <clueLoc>by PBMC</clueLoc> was observed also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NER T29,T30 MOD</comment></event>
<event id="E31">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T28"/>
<clue>Inhibition of cytokine production by PBMC was observed also <linkCause>when</linkCause> <corefCause>other inducers</corefCause> were <linkCause>used</linkCause> (staphylococci, silica, zymosan).</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E32">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T29"/>
<clue>Inhibition of cytokine production by PBMC was observed also <linkCause>when</linkCause> <corefCause>other inducers</corefCause> were <linkCause>used</linkCause> (staphylococci, silica, zymosan).</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E33">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T30"/>
<clue>Inhibition of cytokine production by PBMC was observed also <linkCause>when</linkCause> <corefCause>other inducers</corefCause> were <linkCause>used</linkCause> (staphylococci, silica, zymosan).</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T6"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E134">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T6"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E234">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T6"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E235">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T8"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E236">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T8"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E237">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T8"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E238">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T10"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E239">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T10"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E240">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T10"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E338">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T11"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E339">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T11"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E340">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T11"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E241">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T13"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E242">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T13"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E243">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T13"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> cytokine production by PBMC was <clueType><clueKT>observed</clueKT></clueType> also when other inducers were used (staphylococci, silica, zymosan).</clue>
<comment>NO COREFCAUSE</comment></event>
<sentence id="S5">Much higher concentrations of other <term id="T31" lex="antioxidants" sem="Organic_compound_other">antioxidants</term>--including <term id="T32" lex="ascorbic_acid" sem="Organic_compound_other">ascorbic acid</term>, <term id="T33" lex="trolox" sem="Organic_compound_other">trolox</term>, <term id="T34" lex="alpha-tocopherol" sem="Organic_compound_other">alpha-tocopherol</term>, <term id="T35" lex="butylated_hydroxytoluene" sem="Organic_compound_other">butylated hydroxytoluene</term>, and the <term id="T36" lex="5-lipoxygenase_inhibitor" sem="Organic_compound_other">5-lipoxygenase inhibitor</term> <term id="T37" lex="zileuton" sem="Organic_compound_other">zileuton</term>--did not affect the production of these <term id="T38" lex="cytokine" sem="Protein_family_or_group">cytokines</term>.</sentence>
<event id="E35">
<type class="Gene_expression"/>
<theme idref="T14"/>
<clue>Much higher concentrations of other antioxidants--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did not affect the <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>these cytokines</corefTheme>.</clue>
</event>
<event id="E36">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>Much higher concentrations of other antioxidants--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did not affect the <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>these cytokines</corefTheme>.</clue>
</event>
<event id="E37">
<type class="Gene_expression"/>
<theme idref="T16"/>
<clue>Much higher concentrations of other antioxidants--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did not affect the <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>these cytokines</corefTheme>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E38">
<type class="Regulation"/>
<theme idref="E35"/>
<cause idref="T31"/>
<clue>Much higher concentrations of other antioxidants--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E39">
<type class="Regulation"/>
<theme idref="E36"/>
<cause idref="T31"/>
<clue>Much higher concentrations of other antioxidants--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E40">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T31"/>
<clue>Much higher concentrations of other antioxidants--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E41">
<type class="Regulation"/>
<theme idref="E35"/>
<cause idref="T32"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E42">
<type class="Regulation"/>
<theme idref="E36"/>
<cause idref="T32"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E43">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T32"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E44">
<type class="Regulation"/>
<theme idref="E35"/>
<cause idref="T33"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E45">
<type class="Regulation"/>
<theme idref="E36"/>
<cause idref="T33"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E46">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T33"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E47">
<type class="Regulation"/>
<theme idref="E35"/>
<cause idref="T34"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E48">
<type class="Regulation"/>
<theme idref="E36"/>
<cause idref="T34"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E49">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T34"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E50">
<type class="Regulation"/>
<theme idref="E35"/>
<cause idref="T35"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E51">
<type class="Regulation"/>
<theme idref="E36"/>
<cause idref="T35"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E52">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T35"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E53">
<type class="Regulation"/>
<theme idref="E35"/>
<cause idref="T37"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E54">
<type class="Regulation"/>
<theme idref="E36"/>
<cause idref="T37"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E55">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T37"/>
<clue>Much higher concentrations of <corefCause>other antioxidants</corefCause>--including ascorbic acid, trolox, alpha-tocopherol, butylated hydroxytoluene, and the 5-lipoxygenase inhibitor zileuton--did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the production of these cytokines.</clue>
</event>
<sentence id="S6">The active compounds did not inhibit <term id="T39" lex="IL-1-induced_production" sem="Other"><term id="T40" lex="IL-1" sem="Protein_molecule">IL-1</term>-induced production</term> of <term id="T41" lex="IL-6" sem="Protein_molecule">IL-6</term> in <term id="T42" lex="fibroblast" sem="Cell_natural">fibroblasts</term>, showing the <term id="T43" lex="cell_selectivity" sem="Other">cell selectivity</term> of the effect.</sentence>
<event id="E56">
<type class="Gene_expression"/>
<theme idref="T41"/>
<clue>The active compounds did not inhibit IL-1-induced <clueType>production</clueType> <linkTheme>of</linkTheme> IL-6 <clueLoc>in fibroblasts</clueLoc>, showing the cell selectivity of the effect.</clue>
</event>
<event id="E57">
<type class="Positive_regulation"/>
<theme idref="E56"/>
<cause idref="T40"/>
<clue>The active compounds did not inhibit IL-1-<clueType>induced</clueType> production of IL-6 in fibroblasts, showing the cell selectivity of the effect.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E58">
<type class="Negative_regulation"/>
<theme idref="E57"/>
<cause idref="T8"/>
<clue><corefCause>The active compounds</corefCause> did <cluePolarity>not</cluePolarity> <clueType>inhibit</clueType> IL-1-induced production of IL-6 in fibroblasts, showing the cell selectivity of the effect.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E59">
<type class="Negative_regulation"/>
<theme idref="E57"/>
<cause idref="T10"/>
<clue><corefCause>The active compounds</corefCause> did <cluePolarity>not</cluePolarity> <clueType>inhibit</clueType> IL-1-induced production of IL-6 in fibroblasts, showing the cell selectivity of the effect.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E60">
<type class="Negative_regulation"/>
<theme idref="E57"/>
<cause idref="T11"/>
<clue><corefCause>The active compounds</corefCause> did <cluePolarity>not</cluePolarity> <clueType>inhibit</clueType> IL-1-induced production of IL-6 in fibroblasts, showing the cell selectivity of the effect.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E61">
<type class="Negative_regulation"/>
<theme idref="E57"/>
<cause idref="T13"/>
<clue><corefCause>The active compounds</corefCause> did <cluePolarity>not</cluePolarity> <clueType>inhibit</clueType> IL-1-induced production of IL-6 in fibroblasts, showing the cell selectivity of the effect.</clue>
</event>
<sentence id="S7"><term id="T44" lex="antioxidant-mediated_inhibition" sem="Other"><term id="A1" sem="Organic_compound_other">Antioxidant</term>-mediated inhibition</term> of <term id="T45" lex="cytokine_production" sem="Other"><term id="T46" lex="cytokine" sem="Protein_family_or_group">cytokine</term> production</term> was correlated with low levels of the corresponding <term id="T47" lex="messenger_RNA" sem="RNA_family_or_group">messenger RNAs</term>.</sentence>
<event KT="Other" id="E62">
<type class="Gene_expression"/>
<theme idref="T46"/>
<clue>Antioxidant-mediated inhibition of cytokine <clueType>production</clueType> was correlated with low levels of the corresponding messenger RNAs.</clue>
</event>
<event KT="Other" id="E63">
<type class="Negative_regulation"/>
<theme idref="E62"/>
<cause idref="A1"/>
<clue>Antioxidant-<linkCause>mediated</linkCause> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> cytokine production was correlated with low levels of the corresponding messenger RNAs.</clue>
</event>
<event KT="Other" Manner="Low" id="E64">
<type class="Negative_regulation"/>
<theme idref="T46" idref1="T47"/>
<clue>Antioxidant-mediated inhibition of cytokine production was correlated with <clueType><clueManner>low levels</clueManner></clueType> <linkTheme>of</linkTheme> <corefTheme>the corresponding messenger RNAs</corefTheme>.</clue>
</event>
<event KT="Analysis" id="E65">
<type class="Correlation"/>
<theme idref="E63"/>
<theme idref="E64"/>
<clue>Antioxidant-mediated inhibition of cytokine production was <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> low levels of the corresponding messenger RNAs.</clue>
</event>
<sentence id="S8">Nuclear run-on experiments showed that <term id="T48" lex="THP" sem="Organic_compound_other">THP</term> inhibited transcription of the <term id="T49" lex="IL-1_beta_gene" sem="DNA_domain_or_region"><term id="T50" lex="IL-1_beta" sem="Protein_molecule"><term id="T51" lex="IL-1" sem="Protein_molecule">IL-1</term> beta</term> gene</term>.</sentence>
<event KT="Other" id="E66">
<type class="Transcription"/>
<theme idref="T49"/>
<clue>Nuclear run-on experiments showed that THP inhibited <clueType>transcription</clueType> <linkTheme>of</linkTheme> the IL-1 beta gene.</clue>
</event>
<event KT="Analysis" id="E67">
<type class="Negative_regulation"/>
<theme idref="E66"/>
<cause idref="T48"/>
<clue><clueExperiment>Nuclear run-on experiments</clueExperiment> <clueKT>showed</clueKT> that THP <clueType>inhibited</clueType> transcription of the IL-1 beta gene.</clue>
</event>
<sentence id="S9"><term id="T52" lex="THP" sem="Organic_compound_other">THP</term> decreased the concentration of the <term id="T53" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> <term id="T54" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> and <term id="T55" lex="AP-1" sem="Protein_molecule">AP-1</term> detected in <term id="T56" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> of <term id="T57" lex="PBMC" sem="Cell_natural">PBMC</term> cultured in the presence or absence of <term id="T58" lex="LPS" sem="Lipid">LPS</term>.</sentence>
<event id="E68">
<type class="Negative_regulation"/>
<theme idref="T54"/>
<cause idref="T52"/>
<clue>THP <clueType>decreased</clueType> the concentration of the transcription factors NF-kappa B and AP-1 detected <clueLoc>in nuclear extracts of PBMC cultured in the presence</clueLoc> or absence <clueLoc>of LPS</clueLoc>.</clue>
</event>
<event id="E168">
<type class="Negative_regulation"/>
<theme idref="T54"/>
<cause idref="T52"/>
<clue>THP <clueType>decreased</clueType> the concentration of the transcription factors NF-kappa B and AP-1 detected <clueLoc>in nuclear extracts of PBMC cultured in the</clueLoc> presence or <clueLoc>absence of LPS</clueLoc>.</clue>
</event>
<event id="E69">
<type class="Negative_regulation"/>
<theme idref="T55"/>
<cause idref="T52"/>
<clue>THP <clueType>decreased</clueType> the concentration of the transcription factors NF-kappa B and AP-1 detected <clueLoc>in nuclear extracts of PBMC cultured in the presence</clueLoc> or absence <clueLoc>of LPS</clueLoc>.</clue>
</event>
<event id="E169">
<type class="Negative_regulation"/>
<theme idref="T55"/>
<cause idref="T52"/>
<clue>THP <clueType>decreased</clueType> the concentration of the transcription factors NF-kappa B and AP-1 detected <clueLoc>in nuclear extracts of PBMC cultured in the</clueLoc> presence or <clueLoc>absence of LPS</clueLoc>.</clue>
</event>
<sentence id="S10"><term id="T59" lex="THP" sem="Organic_compound_other">THP</term> and <term id="T60" lex="DHA" sem="Organic_compound_other">DHA</term> markedly decreased the levels of <term id="T61" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term> and <term id="T62" lex="IL-1_beta" sem="Protein_molecule"><term id="T63" lex="IL-1" sem="Protein_molecule">IL-1</term> beta</term> in the circulation of <term id="T64" lex="mice" sem="Multicellular_organism_natural">mice</term> following <term id="T65" lex="LPS" sem="Lipid">LPS</term> injection.</sentence>
<event id="E70">
<type class="Gene_expression"/>
<theme idref="T61"/>
<clue>THP and DHA markedly decreased the <clueType>levels</clueType> <linkTheme>of</linkTheme> TNF-alpha and IL-1 beta <clueLoc>in the circulation of mice</clueLoc> <clueTime>following LPS injection</clueTime>.</clue>
</event>
<event id="E71">
<type class="Gene_expression"/>
<theme idref="T62"/>
<clue>THP and DHA markedly decreased the <clueType>levels</clueType> <linkTheme>of</linkTheme> TNF-alpha and IL-1 beta <clueLoc>in the circulation of mice</clueLoc> <clueTime>following LPS injection</clueTime>.</clue>
</event>
<event Manner="High" id="E74">
<type class="Negative_regulation"/>
<theme idref="E70"/>
<cause idref="T59"/>
<clue>THP and DHA <clueManner>markedly</clueManner> <clueType>decreased</clueType> the levels of TNF-alpha and IL-1 beta in the circulation of mice following LPS injection.</clue>
</event>
<event Manner="High" id="E75">
<type class="Negative_regulation"/>
<theme idref="E71"/>
<cause idref="T59"/>
<clue>THP and DHA <clueManner>markedly</clueManner> <clueType>decreased</clueType> the levels of TNF-alpha and IL-1 beta in the circulation of mice following LPS injection.</clue>
</event>
<event Manner="High" id="E76">
<type class="Negative_regulation"/>
<theme idref="E70"/>
<cause idref="T60"/>
<clue>THP and DHA <clueManner>markedly</clueManner> <clueType>decreased</clueType> the levels of TNF-alpha and IL-1 beta in the circulation of mice following LPS injection.</clue>
</event>
<event Manner="High" id="E77">
<type class="Negative_regulation"/>
<theme idref="E71"/>
<cause idref="T60"/>
<clue>THP and DHA <clueManner>markedly</clueManner> <clueType>decreased</clueType> the levels of TNF-alpha and IL-1 beta in the circulation of mice following LPS injection.</clue>
</event>
<sentence id="S11">Thus <term id="T66" lex="antioxidants" sem="Organic_compound_other">antioxidants</term> vary widely in potency as inhibitors of the activation of <term id="T67" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> and of the transcription of <term id="A3" sem="DNA_domain_or_region"><term id="T68" lex="gene" sem="DNA_family_or_group">genes</term> for <term id="T69" lex="pro-inflammatory_cytokine" sem="Protein_family_or_group">pro-inflammatory <term id="T70" lex="cytokine" sem="Protein_family_or_group">cytokines</term></term></term>.</sentence>
<event KT="Other" id="E78">
<type class="Positive_regulation"/>
<theme idref="T67"/>
<clue>Thus antioxidants vary widely in potency as inhibitors of the <clueType>activation</clueType> <linkTheme>of</linkTheme> transcription factors and of the transcription of genes for pro-inflammatory cytokines.</clue>
<comment>TPS A3</comment></event>
<event KT="Other" id="E79">
<type class="Transcription"/>
<theme idref="A3"/>
<clue>Thus antioxidants vary widely in potency as inhibitors of the activation of transcription factors and of the <clueType>transcription</clueType> <linkTheme>of</linkTheme> genes for pro-inflammatory cytokines.</clue>
</event>
<event KT="Analysis" id="E80">
<type class="Negative_regulation"/>
<theme idref="E78"/>
<cause idref="T66"/>
<clue><clueKT>Thus</clueKT> antioxidants vary widely in potency as <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> the activation of transcription factors and of the transcription of genes for pro-inflammatory cytokines.</clue>
</event>
<event KT="Analysis" id="E81">
<type class="Negative_regulation"/>
<theme idref="E79"/>
<cause idref="T66"/>
<clue><clueKT>Thus</clueKT> antioxidants vary widely in potency as <clueType>inhibitors</clueType> of the activation of transcription factors and <linkTheme>of</linkTheme> the transcription of genes for pro-inflammatory cytokines.</clue>
</event>
<sentence id="S12">Coordinate inhibition of the <term id="T71" lex="transcription" sem="Other">transcription</term> of <term id="A4" sem="DNA_domain_or_region">genes for <term id="T72" lex="cytokine" sem="Protein_family_or_group">inflammatory cytokines</term></term> could provide a strategy for therapy of <term id="T73" lex="disease" sem="Other">diseases</term> with <term id="T74" lex="inflammatory_pathogenesis" sem="Other">inflammatory pathogenesis</term> and for <term id="T75" lex="septic_shock" sem="Other">septic shock</term>.</sentence>
<event KT="Other" id="E82">
<type class="Transcription"/>
<theme idref="A4"/>
<clue>Coordinate inhibition of the <clueType>transcription</clueType> <linkTheme>of</linkTheme> genes for inflammatory cytokines could provide a strategy for therapy of diseases with inflammatory pathogenesis and for septic shock.</clue>
<comment>TPS A4, NER T72 MOD</comment></event>
<event CL="L1" KT="Analysis" id="E83">
<type class="Negative_regulation"/>
<theme idref="E82"/>
<clue>Coordinate <clueType>inhibition</clueType> <linkTheme>of</linkTheme> the transcription of genes for inflammatory cytokines <clueKT><clueCL>could</clueCL></clueKT> provide a strategy for therapy of diseases with inflammatory pathogenesis and for septic shock.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
